Innovent and Lilly Jointly Release Phase 3 Results of TYVYT (Sintilimab Injection) in Combination with GEMZAR (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020

Source :: PR Newswire. September 20, 2020
Publication Year :: 2020
Abstract: SAN FRANCISCO and SUZHOU, China, Sept. 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment [...]

Subjects :: Eli Lilly and Co. -- Product development -- Political activity
Carboplatin -- Product development -- Research
Gemcitabine -- Product development -- Research
Pemetrexed -- Product development -- Research
Clinical trials -- Research -- Political aspects
Adalimumab -- Research -- Product development
Lung cancer, Non-small cell -- Research -- Care and treatment
Pharmaceutical industry -- Product development -- Political activity
Business
News, opinion and commentary
Gemzar (Medication) -- Political aspects -- Research -- Product development

Tools